MOLECULAR DOCKING STUDY OF EPIGALLOCATECHIN GALLATE ON FLT3 IN COMPLEX WITH GILTERITINIB FOR ANTICANCER ACTIVITY

Authors

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i1.48733

Keywords:

Cancer, Epigallocatechin gallate, Auto dock, Molecular docking

Abstract

Objective: The aim of the study was to predict the binding affinity and interaction patterns between EGCG and FLT3 in complex with gilteritinib using molecular docking simulations. stabilization of the EGCG-FLT3-gilteritinib complex.

Methods: The crystal structure of FLT3 in complex with gilteritinib was downloaded from the Protein Data Bank (PDB) database. Epigallocatechin gallate (EGCG) was obtained from the PubChem database. Auto Dock 8 software was utilized for the molecular docking study. The docking results are analyzed to identify the best pose based on binding affinity, hydrogen bonding, and other favorable interactions. The Discovery Studio Visualizer or other suitable software was used to visualize the protein-ligand interactions and analyze the binding mode of EGCG within the FLT3-gilteritinib complex.

Results: The best ranking for ligands binding was at run 7 with the estimated free energy of binding −7.87 kcal/mol the estimated inhibition constant (ki) was 1.69 μm. The final intermolecular energy was −11.45 kcal/mol. kcal/mol It had 12 active torsions. The redocking score using gilteritinib was used as a control for the validation of the study. The estimated free energy of binding was −7.91 kcal/mol. The estimated inhibition constant ki is 1.60 μm. It had nine active torsions.

Conclusion: Comparing the various binding energies and torsions of the test compound and the control revealed that the test epigallocatechin had a perfect docking score, and it was predicted to possess comparable anti-tumor and anticancer activity.

Downloads

Download data is not yet available.

References

Chacko S, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: A literature review. Chin Med 2010;5:13. doi: 1186/1749- 8546-5-13, PMID 20370896

Filippini T, Malavolti M, Borrelli F, Izzo AA, Fairweathert-Tait SJ, Horneber M, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2020;3:CD005004. doi: 10.1002/14651858.CD005004, PMID 32118296

Zhou CG, Hui LM. Epigallocatechin gallate inhibits the proliferation and induces apoptosis of multiple myeloma cells via inactivating EZH2. Eur Rev Med Pharmacol Sci 2008;22:2093-8. doi: 10.26355/ eurrev_201804_14742, PMID: 29687868

Nakazato T, Ito K, Ikeda Y, Kizaki M. Green tea component, catechin, induces apoptosis of human malignant b cell via production of reactive oxygen species. Clin Cancer Res 2005;11:6040-9. doi: 10.1158/1078- 0432.CCR-04-2273, PMID: 16115949

Zhang J, Cui H, Qiu J, Wang X, Zhong Y, Yao C, et al. Stability of glycosylated complex loaded with Epigallocatechin 3-gallate (EGCG). Food Chem 2022;410:135364. doi: 10.1016/jfoodchem.2022.135364, PMID 36623458

Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol 2008;443:365-82. doi: 10.1007/978-1-59745-177-2_19, PMID18446297

Geromichalos GD. Importance of molecular computer modelling in anticancer drug development J BUON 2007;12 Suppl 1:S101-18. PMID: 17935268

Huey R, Morris GM, Forli S. Using AutoDock4 and Auto Dock Vina with Auto Dock Tools: A Tutorial. California, USA: The Scripps Research Institute, Molecular Graphic Laboratory; 2012. p. 5-19.

Published

07-01-2024

How to Cite

KURIAN, T. “MOLECULAR DOCKING STUDY OF EPIGALLOCATECHIN GALLATE ON FLT3 IN COMPLEX WITH GILTERITINIB FOR ANTICANCER ACTIVITY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 1, Jan. 2024, pp. 5-7, doi:10.22159/ajpcr.2024.v17i1.48733.

Issue

Section

Short Communication(s)